Ticker history: JUNE became SUPX (SuperX AI Technology Limited) on . Earlier news and filings retain their original names and dates. View JUNE history.
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SUPX SEC filings page.
SuperX AI Technology Limited (SUPX) reported $20.3M in revenue for fiscal year 2026, up 1878.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
Sales rebounded sharply, but costs and overhead still overwhelm revenue, leaving SuperX dependent on financing rather than operating cash generation.
FY2026 revenue rebounded1878.6% , but cost of revenue still exceeded sales, leaving the core transaction unprofitable. Operating cash flow moved from$45.1K in FY2023 to-$73.8M in FY2026, showing that greater reported scale has not translated into internally generated cash.
The resource demands are far ahead of commercial scale: SG&A consumed
From FY2025 to FY2026, assets grew
Financial Health Signals
We do not publish a peer-relative financial health score for SuperX AI Technology Limited, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
SuperX AI Technology Limited scores 10.21, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $216.5M against total liabilities of $11.2M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
SuperX AI Technology Limited passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
SuperX AI Technology Limited reported a net loss of $107.3M while operations used $73.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
SuperX AI Technology Limited reported an operating loss of $101.7M against $9K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
SuperX AI Technology Limited generated $20.3M in revenue in fiscal year 2026. This represents an increase of 1878.6% from the prior year.
SuperX AI Technology Limited's EBITDA was -$100.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.
SuperX AI Technology Limited reported a net loss of $107.3M in fiscal year 2026. The change from the prior year is not meaningful, because that figure was zero or negative.
SuperX AI Technology Limited earned -$2.89 per diluted share (EPS) in fiscal year 2026.
Cash & Balance Sheet
SuperX AI Technology Limited recorded an outflow of $79.2M in free cash flow in fiscal year 2026, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
SuperX AI Technology Limited held $98.9M in cash against $2.2M in long-term debt as of fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
SuperX AI Technology Limited's gross margin was -5.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 10.4 percentage points from the prior year.
SuperX AI Technology Limited's ROE was -56.2% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 50.8 percentage points from the prior year.
Not shown for fiscal year 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for fiscal year 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
SuperX AI Technology Limited spent $18.2M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding.
SuperX AI Technology Limited invested $5.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 1727.4% from the prior year.
Not reported for fiscal year 2026.
SUPX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Revenue | $20.3M+1878.6% | $1.0M-64.6% | $2.9M-52.7% | $6.1M-36.2% | $9.6M |
| Cost of Revenue | $21.4M+2094.7% | $977K-53.2% | $2.1M-57.1% | $4.9M-40.5% | $8.2M |
| Gross Profit | -$1.1M-2229.5% | $51K-93.7% | $818K-36.0% | $1.3M-11.7% | $1.4M |
| R&D Expenses | N/A | $1.2M | N/A | N/A | N/A |
| SG&A Expenses | $100.6M+765.2% | $11.6M+1056.1% | $1.0M-26.9% | $1.4M-17.7% | $1.7M |
| Operating Income | -$101.7Mn/m | -$20.9Mn/m | -$999Kn/m | -$99Kn/m | -$224K |
| EBITDA | -$100.3Mn/m | -$20.9Mn/m | -$988Kn/m | -$89Kn/m | -$202K |
| Interest Expense | $9K+6029.3% | $147-98.7% | $12K-20.7% | $15K-7.1% | $16K |
| Income Tax | $9Kn/m | -$35K-579.0% | $7K-86.9% | $56K+3.9% | $54K |
| Net Income | -$107.3Mn/m | -$21.2Mn/m | -$855K-2310.4% | $39Kn/m | -$66K |
| EPS (Basic) | -$2.89 | -$1.41n/m | -$0.08-2025.0% | $0.00n/m | -$0.01 |
| EPS (Diluted) | -$2.89 | -$1.41n/m | -$0.08-2025.0% | $0.00n/m | -$0.01 |
| Diluted Shares (Avg) | 37M | 15M+35.4% | 11M+3.9% | 11M0.0% | 11M |
SUPX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Total Assets | $202.7M+289.4% | $52.1M+550.1% | $8.0M+225.1% | $2.5M | N/A |
| Current Assets | $186.5M+377.8% | $39.0M+396.2% | $7.9M+447.1% | $1.4M | N/A |
| Cash & Equivalents | $98.9M+482.0% | $17.0M+134.7% | $7.2M+1197.5% | $558K-44.1% | $999K |
| Short-Term Investments | $8.0M | N/A | $0n/m | $0n/m | $0 |
| Inventory | $31.1M | N/A | N/A | N/A | N/A |
| Accounts Receivable | $472K+155.1% | $185K-28.2% | $258K-66.4% | $767K | N/A |
| Long-Term Investments | N/A | $967Kn/m | $0n/m | $0n/m | $0 |
| Total Liabilities | $11.2M-65.3% | $32.2M+2994.2% | $1.0M-24.0% | $1.4M | N/A |
| Current Liabilities | $9.5M-70.3% | $31.8M+3239.1% | $953K-15.8% | $1.1M | N/A |
| Non-Current Liabilities | $1.7M+351.4% | $386K+338.5% | $88K-63.0% | $237K | N/A |
| Long-Term Debt | $2.2M+1854.0% | $114K+41.1% | $81K-66.0% | $237K | N/A |
| Total Equity | $191.1M+863.9% | $19.8M+184.7% | $7.0M+537.4% | $1.1M-9.3% | $1.2M |
| Retained Earnings | -$128.3Mn/m | -$22.3Mn/m | -$1.1Mn/m | -$247K | N/A |
Not reported in any period shown, so not listed: Goodwill.
SUPX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Operating Cash Flow | -$73.8Mn/m | -$8.3Mn/m | -$752K-1768.0% | $45Kn/m | -$229K |
| Depreciation & Amortization | $1.4M+1814.7% | $73K+592.0% | $11K+8.2% | $10K-55.9% | $22K |
| Stock-Based Compensation | $52.4M+1353.0% | $3.6M | N/A | N/A | N/A |
| Capital Expenditures | $5.4M+1727.4% | $298K+4453.9% | $7K-55.3% | $15K+28.6% | $11K |
| Free Cash Flow | -$79.2Mn/m | -$8.6Mn/m | -$758K-2590.4% | $30Kn/m | -$240K |
| Investing Cash Flow | -$30.6Mn/m | -$12.4Mn/m | -$7Kn/m | -$15Kn/m | -$11K |
| Financing Cash Flow | $186.2M+507.0% | $30.7M+313.0% | $7.4Mn/m | -$473K-326.3% | $209K |
| Dividends Paid | N/A | N/A | N/A | $153K-12.2% | $174K |
| Share Buybacks | $18.2M | N/A | N/A | N/A | N/A |
SUPX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Gross Margin | -5.4%-10.4pp | 5.0%-23.2pp | 28.2%+7.4pp | 20.8%+5.8pp | 15.0% |
| Operating Margin | -500.2% | -2036.9% | -34.4%-32.8pp | -1.6%+0.7pp | -2.3% |
| Net Margin | -527.7% | -2063.5% | -29.4%-30.1pp | 0.6%+1.3pp | -0.7% |
| Return on Equity | -56.2%+50.8pp | -107.0%-94.7pp | -12.3%-15.8pp | 3.5%+9.0pp | -5.5% |
| Return on Assets | -53.0%-12.2pp | -40.8%-30.1pp | -10.7%-12.3pp | 1.6% | N/A |
| Current Ratio | 19.73+18.5x | 1.23-7.0x | 8.25+7.0x | 1.27 | N/A |
| Debt-to-Equity | 0.010.0x | 0.010.0x | 0.01-0.2x | 0.22 | N/A |
| Liabilities-to-Equity | 0.06-1.6x | 1.63+1.5x | 0.15-1.1x | 1.25 | N/A |
| Asset Turnover | 0.10+0.1x | 0.02-0.3x | 0.36-2.1x | 2.49 | N/A |
| FCF Margin | -389.5% | -839.7% | -26.1%-26.6pp | 0.5%+3.0pp | -2.5% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| SuperX AI Technology Limited SUPX | FY2026 | $20.3M | -$107.3M | N/A | $216.5M | — |
| Xunlei Limited XNET | FY2025 | $462.4M | $1.0B | N/A | $225.6M | 54/100 |
| New Era Energy & Digital, Inc. NUAI | FY2025 | $885K | -$29.6M | N/A | $242.8M | — |
| International Money Express, Inc. IMXI | FY2025 | $607.8M | $32.7M | 5.4% | $221.8M | 61/100 |
| Bakkt, Inc. BKKT | FY2025 | N/A | -$107.2M | N/A | $193.8M | — |
| Gorilla Technology Group Inc. GRRR | FY2025 | $101.4M | -$11.3M | -11.1% | $190.1M | 33/100 |
Where SuperX AI Technology Limited Ranks
Frequently Asked Questions
SuperX AI Technology Limited (SUPX) reported $20.3M in total revenue for fiscal year 2026. This represents a 1878.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
SuperX AI Technology Limited (SUPX) revenue grew by 1878.6% year-over-year, from $1.0M to $20.3M in fiscal year 2026.
No, SuperX AI Technology Limited (SUPX) reported a net loss of $107.3M in fiscal year 2026.
SuperX AI Technology Limited (SUPX) had EBITDA of -$100.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2026, SuperX AI Technology Limited (SUPX) had $98.9M in cash and equivalents against $2.2M in long-term debt.
SuperX AI Technology Limited (SUPX) had a gross margin of -5.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
SuperX AI Technology Limited (SUPX) has a return on equity of -56.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
SuperX AI Technology Limited (SUPX) recorded an outflow of $79.2M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
SuperX AI Technology Limited (SUPX) recorded an outflow of $73.8M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
SuperX AI Technology Limited (SUPX) had $202.7M in total assets as of fiscal year 2026, including both current and long-term assets.
SuperX AI Technology Limited (SUPX) invested $5.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
SuperX AI Technology Limited (SUPX) had a current ratio of 19.73 as of fiscal year 2026, which is generally considered healthy.
SuperX AI Technology Limited (SUPX) had a debt-to-equity ratio of 0.01 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
SuperX AI Technology Limited (SUPX) had a liabilities-to-equity ratio of 0.06 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
SuperX AI Technology Limited (SUPX) had a return on assets of -53.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
SuperX AI Technology Limited (SUPX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $216.5M as of Nov 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
SuperX AI Technology Limited (SUPX) trades at 10.6x sales, its market capitalization divided by $20.3M revenue, FY2026. The market capitalization is $216.5M as of Nov 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
SuperX AI Technology Limited (SUPX) has an Altman Z-Score of 10.21, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
SuperX AI Technology Limited (SUPX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
SuperX AI Technology Limited (SUPX) reported a net loss of $107.3M while operations used $73.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
SuperX AI Technology Limited (SUPX) reported an operating loss of $101.7M against $9K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.